Hondermarck Hubert, Bartlett Nathan W, Nurcombe Victor
School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine University of Newcastle Callaghan NSW Australia.
Hunter Medical Research Institute University of Newcastle New Lambton Heights NSW Australia.
FASEB Bioadv. 2020 Apr 11;2(5):296-303. doi: 10.1096/fba.2020-00015. eCollection 2020 May.
Growth factor receptors are known to be involved in the process of viral infection. Many viruses not only use growth factor receptors to physically attach to the cell surface and internalize, but also divert receptor tyrosine kinase signaling in order to replicate. Thus, repurposing drugs that have initially been developed to target growth factor receptors and their signaling in cancer may prove to be a fast track to effective therapies against emerging new viral infections, including the coronavirus disease 19 (COVID-19).
已知生长因子受体参与病毒感染过程。许多病毒不仅利用生长因子受体在物理上附着于细胞表面并内化,还会改变受体酪氨酸激酶信号传导以进行复制。因此,重新利用最初开发用于靶向癌症中生长因子受体及其信号传导的药物,可能会成为对抗包括新型冠状病毒肺炎(COVID-19)在内的新出现病毒感染的有效治疗的快速途径。